Cryo-Cell International I... (CCEL)
NASDAQ: CCEL
· Real-Time Price · USD
4.87
0.07 (1.46%)
At close: May 23, 2025, 10:22 AM
Cryo-Cell International Revenue Breakdown
| Period Ending | Nov 30, 2024 | Nov 30, 2023 | Nov 30, 2022 | Nov 30, 2021 | Nov 30, 2020 | Nov 30, 2019 | Nov 30, 2018 |
|---|---|---|---|---|---|---|---|
| Processing And Storage Fees Revenue | 31.55M | 30.8M | 29.77M | 28.4M | 29.55M | 172.4K | 104.32K |
| Processing And Storage Fees Revenue Growth | +2.45% | +3.44% | +4.84% | -3.89% | +17039.22% | +65.25% | n/a |
| Product Revenue | 67.88K | 66.46K | 104K | 111.4K | 244.19K | 652.2K | 296.3K |
| Product Revenue Growth | +2.15% | -36.10% | -6.64% | -54.38% | -62.56% | +120.12% | n/a |
| Public Banking Revenue | 366.67K | 481.15K | 461.63K | 376.1K | 726.55K | n/a | n/a |
| Public Banking Revenue Growth | -23.79% | +4.23% | +22.74% | -48.23% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 | May 31, 2018 | Feb 28, 2018 | Nov 30, 2017 | Aug 31, 2017 | May 31, 2017 | Feb 28, 2017 | Nov 30, 2016 | Aug 31, 2016 | May 31, 2016 | Feb 29, 2016 | Nov 30, 2015 | Aug 31, 2015 | May 31, 2015 | Feb 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.64M | 6.01M | 4.15M | 4.02M | 4.34M | 5.39M | 3.8M | 4.04M | 3.88M | 4.69M | 3.6M | 3.91M | 3.38M | 4.55M | 3.49M | 3.15M | 3.43M | 3.49M | 3.38M | 3.56M | 3.87M | 3.94M | 3.56M | 3.65M | 3.75M | 4.12M | 4.39M | 3.53M | 3.59M | 3.54M | 3.43M | 3.41M | 3.1M | 3.81M | 3.91M | 3.41M | 3.6M | 3.84M | 2.63M | 3.01M | 2.91M |
| Selling, General, and Administrative Revenue Growth | -22.83% | +44.84% | +3.19% | -7.33% | -19.53% | +41.75% | -5.80% | +4.13% | -17.26% | +30.11% | -7.90% | +15.90% | -25.80% | +30.23% | +10.97% | -8.30% | -1.62% | +3.38% | -5.14% | -8.05% | -1.82% | +10.83% | -2.50% | -2.60% | -9.08% | -6.17% | +24.27% | -1.57% | +1.45% | +3.08% | +0.61% | +10.12% | -18.65% | -2.64% | +14.85% | -5.32% | -6.31% | +46.05% | -12.57% | +3.18% | n/a |
| Research and Development Revenue | 98.14K | 304.63K | 193.93K | 241.09K | 502.89K | 443.81K | 344.13K | 304.68K | 78.83K | 76.4K | 80.27K | 80.9K | 147.22K | 30.44K | 10K | 3.24K | 6.19K | 7.06K | 1.25K | 9.82K | 5.72K | 16.86K | 2.44K | 4.96K | 5.88K | 26.92K | 22.23K | 29.28K | 13.41K | 17.48K | 226 | 8.84K | 14.62K | 18.64K | 13.78K | 11.99K | 8.68K | 13.31K | 9.95K | 10.53K | 11.99K |
| Research and Development Revenue Growth | -67.78% | +57.08% | -19.56% | -52.06% | +13.31% | +28.96% | +12.95% | +286.49% | +3.18% | -4.82% | -0.77% | -45.05% | +383.66% | +204.27% | +209.05% | -47.71% | -12.32% | +465.71% | -87.29% | +71.64% | -66.07% | +591.15% | -50.78% | -15.75% | -78.14% | +21.07% | -24.07% | +118.39% | -23.30% | +7635.84% | -97.44% | -39.52% | -21.61% | +35.30% | +14.95% | +38.05% | -34.75% | +33.73% | -5.50% | -12.15% | n/a |